Literature DB >> 9311808

Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle.

J Enssle1, N Fischer, A Moebes, B Mauer, U Smola, A Rethwilm.   

Abstract

Foamy viruses (FVs) express the Gag protein as a precursor with a molecular mass of 74 kDa (pr74) from which a 70-kDa protein (p70) is cleaved by the viral protease. To gain a better understanding of FV Gag protein processing and function, we have generated and analyzed mutants in the C-terminal gag region of an infectious molecular clone. Our results show that p70 is an N-terminal cleavage product of pr74. However, we were unable to identify a p4 molecule. A virus mutant expressing p70 only was found to be replication competent, albeit at very low titers compared to those of wild-type virus. A strong tendency to synthesize and cleave a pr74 molecule was deduced from the occurrence of revertants upon transfection of this mutant. Substitution of the p6gag domain of human immunodeficiency virus type 1 for the p4 domain of FV resulted in a stable chimeric virus which replicated to titers 10 times lower than those of wild-type virus. FV Gag protein was found to be phosphorylated at serine residues. Mutagenesis of serines conserved in the p4 domain had no influence on viral replication in cell culture. The p70/p74 Gag cleavage was found to be required for viral infectivity, since mutagenesis of the putative cleavage site led to replication-incompetent virus. Interestingly, the cleavage site mutants were defective in the intracellular cDNA synthesis of virion DNA, which indicates that correct FV particle formation and the generation of virion DNA are functionally linked.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311808      PMCID: PMC192075          DOI: 10.1128/JVI.71.10.7312-7317.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Human foamy virus reverse transcription that occurs late in the viral replication cycle.

Authors:  A Moebes; J Enssle; P D Bieniasz; M Heinkelein; D Lindemann; M Bock; M O McClure; A Rethwilm
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis.

Authors:  B Duclos; S Marcandier; A J Cozzone
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates.

Authors:  W J Boyle; P van der Geer; T Hunter
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

5.  A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum.

Authors:  P A Goepfert; K L Shaw; G D Ritter; M J Mulligan
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.

Authors:  K Peden; M Emerman; L Montagnier
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

8.  Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step.

Authors:  A Saïb; F Puvion-Dutilleul; M Schmid; J Périès; H de Thé
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Identification of the major immunogenic structural proteins of human foamy virus.

Authors:  K O Netzer; A Rethwilm; B Maurer; V ter Meulen
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

10.  The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains.

Authors:  S F Yu; K Edelmann; R K Strong; A Moebes; A Rethwilm; M L Linial
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

View more
  46 in total

1.  Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging.

Authors:  M Heinkelein; J Thurow; M Dressler; H Imrich; D Neumann-Haefelin; M O McClure; A Rethwilm
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression.

Authors:  Carolyn R Stenbak; Maxine L Linial
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Foamy virus Pol protein expressed as a Gag-Pol fusion retains enzymatic activities, allowing for infectious virus production.

Authors:  Eun-Gyung Lee; Amber Sinicrope; Dana L Jackson; Shuyuarn F Yu; Maxine L Linial
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

Review 4.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

5.  Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation.

Authors:  Eun-Gyung Lee; Jacqueline Roy; Dana Jackson; Patrick Clark; Paul L Boyer; Stephen H Hughes; Maxine L Linial
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

6.  Protease-dependent uncoating of a complex retrovirus.

Authors:  Jacqueline Lehmann-Che; Marie-Lou Giron; Olivier Delelis; Martin Löchelt; Patricia Bittoun; Joelle Tobaly-Tapiero; Hugues de Thé; Ali Saïb
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome.

Authors:  Ingrid Mannigel; Annett Stange; Hanswalter Zentgraf; Dirk Lindemann
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

8.  Basic residues in the foamy virus Gag protein.

Authors:  Daniel Matthes; Tatiana Wiktorowicz; Juliane Zahn; Jochen Bodem; Nicole Stanke; Dirk Lindemann; Axel Rethwilm
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

9.  Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.

Authors:  S W Eastman; M L Linial
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

10.  Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids.

Authors:  Martin Heinkelein; Cordula Leurs; Matthias Rammling; Katrin Peters; Helmut Hanenberg; Axel Rethwilm
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.